Cargando…

P02-04. Multimeric soluble CD40 ligand efficiently enhances HIV specific cellular immune responses during DNA prime and boost with attenuated poxvirus strains

Detalles Bibliográficos
Autores principales:	Najera, J, Gomez, C, Esteban, M
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767995/ http://dx.doi.org/10.1186/1742-4690-6-S3-P9

Ejemplares similares

Multimeric forms of CD40 ligand (CD40L), 4-1BB ligand (4-1BBL), OX40 ligand (OX40L), CD27L/CD70, and other TNFSFs as tools for adoptive cell therapy
por: Kornbluth, Richard S
Publicado: (2013)

Protection of Rhesus Monkeys by a DNA Prime/Poxvirus Boost Malaria Vaccine Depends on Optimal DNA Priming and Inclusion of Blood Stage Antigens
por: Weiss, Walter R., et al.
Publicado: (2007)

Nanoparticle-Delivered Multimeric Soluble CD40L DNA Combined with Toll-Like Receptor Agonists as a Treatment for Melanoma
por: Stone, Geoffrey W., et al.
Publicado: (2009)

Heterologous prime-boost-boost immunisation of Chinese cynomolgus macaques using DNA and recombinant poxvirus vectors expressing HIV-1 virus-like particles
por: Bridge, Simon H, et al.
Publicado: (2011)

OA04-02. Strong HIV-specific CD4 and CD8 T-lymphocyte proliferation in HIV-1 DNA prime/modified vaccinia virus Ankara (MVA) heterologous boost vaccinees
por: Nilsson, C, et al.
Publicado: (2009)

Elicitation of Both Anti HIV-1 Env Humoral and Cellular Immunities by Replicating Vaccinia Prime Sendai Virus Boost Regimen and Boosting by CD40Lm
por: Zhang, Xianfeng, et al.
Publicado: (2012)

Memorandum: Properties of the 02 and 04 beams
por: Neale, W W
Publicado: (1963)

Highly Attenuated Poxvirus-Based Vaccines Against Emerging Viral Diseases
por: Perdiguero, Beatriz, et al.
Publicado: (2023)

Soluble CD40 ligand is not solely related to the presence and severity of sepsis
por: Chew, Michelle S, et al.
Publicado: (2011)

The Evolution of Poxvirus Vaccines
por: Sánchez-Sampedro, Lucas, et al.
Publicado: (2015)

Levels of human platelet-derived soluble CD40 ligand depend on haplotypes of CD40LG-CD40-ITGA2
por: Aloui, Chaker, et al.
Publicado: (2016)

A soluble multimeric recombinant CD2 protein identifies CD48 as a low affinity ligand for human CD2: divergence of CD2 ligands during the evolution of humans and mice
Publicado: (1993)

Soluble CD40 ligand can replace the normal T cell-derived CD40 ligand signal to B cells in T cell-dependent activation
Publicado: (1993)

Soluble CD40 Ligand in Aspirin-Treated Patients Undergoing Cardiac Catheterization
por: Gremmel, Thomas, et al.
Publicado: (2015)

Soluble CD40 Ligand Levels in Children with Newly Diagnosed Graves’ Disease
por: Metwalley, Kotb Abbass, et al.
Publicado: (2020)

The Proinflammatory Soluble CD40 Ligand Is Associated with the Systemic Extent of Stable Atherosclerosis
por: Pereira-da-Silva, Tiago, et al.
Publicado: (2021)

S04-04 OA. HIV-specific responses induced by anti-CD40 targeting antibodies
por: Loof, N, et al.
Publicado: (2009)

P02-06. The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine
por: Liu, J, et al.
Publicado: (2009)

AD#8 (04.02.98) - Compte rendu
por: Buttkus, J
Publicado: (1998)

Intégration SMACC : Réunion du 04/02/86
por: de Metz-Noblat, N
Publicado: (1986)

Soluble CD40 Ligand Levels in Otherwise Healthy Subjects With Impaired Fasting Glucose
por: Tasci, Ilker, et al.
Publicado: (2006)

Soluble CD40 ligand, a mediator of sepsis or of transfusion-related adverse effects?
por: Tuinman, Pieter R, et al.
Publicado: (2011)

Soluble CD40 ligand and prolactin levels in migraine patients during interictal period
por: Guldiken, Sibel, et al.
Publicado: (2011)

Induction of multi-antigen multi-stage immune responses against Plasmodium falciparum in rhesus monkeys, in the absence of antigen interference, with heterologous DNA prime/poxvirus boost immunization
por: Jiang, George, et al.
Publicado: (2007)

HIV-1 Vaccine Sequences Impact V1V2 Antibody Responses: A Comparison of Two Poxvirus Prime gp120 Boost Vaccine Regimens
por: Shen, Xiaoying, et al.
Publicado: (2020)

Poxvirus tropism
por: McFadden, Grant
Publicado: (2005)

Poxvirus Recombination
por: Evans, David Hugh
Publicado: (2022)

Zoonotic poxviruses()
por: Essbauer, Sandra, et al.
Publicado: (2010)

OX40:OX40L axis: emerging targets for improving poxvirus‐based CD8(+) T‐cell vaccines against respiratory viruses
por: Goulding, John, et al.
Publicado: (2011)

A conformational transition of the D′D3 domain primes von Willebrand factor for multimerization
por: Gruber, Sophia, et al.
Publicado: (2022)

Association between serum soluble CD40 ligand levels and mortality in patients with severe sepsis
por: Lorente, Leonardo, et al.
Publicado: (2011)

OA04-06 LB. Post-infection cellular immune responses in recipients following ALVAC-HIV® + AIDSVAX® B/E prime-boost vaccination in the Thai Phase III Trial
por: Kim, JH, et al.
Publicado: (2009)

ProtoDUNE Final Structure for NP02 and NP04
por: Ordan, Julien Marius
Publicado: (2018)

A Supernova Search At Z = 0.2 - 0.4
por: Hardin, D
Publicado: (2000)

P04.02. An Integrative Approach to Fertility and Preconception Care
por: Maker-Clark, Geeta, et al.
Publicado: (2013)

Oncolytic Poxvirus Armed with Fas Ligand Leads to Induction of Cellular Fas Receptor and Selective Viral Replication in FasR Negative Cancer
por: Sathaiah, Magesh, et al.
Publicado: (2011)

P04-09. Induction of cross-clade neutralizing antibodies with a prime/boost vaccine strategy focused on a neutralizing epitope
por: Zolla-Pazner, S, et al.
Publicado: (2009)

Malaria infection by sporozoite challenge induces high functional antibody titres against blood stage antigens after a DNA prime, poxvirus boost vaccination strategy in Rhesus macaques
por: Mahdi Abdel Hamid, Muzamil, et al.
Publicado: (2011)

Decoding poxvirus genome
por: Yang, Zhilong, et al.
Publicado: (2015)

Plasma concentrations of soluble CD40 ligand in smokers with acute myocardial infarction: a pilot study
por: Kayrak, Mehmet, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_i140kgi9u718dur1f0fkcapaim